Paragon Genomics 产品代理
Paragon Genomics 产品代理
Primon基因组公司总部位于旧金山湾地区，是一家快速成长的精密医药公司。我们获得专利的靶向测序技术CleanPlex®DNA、CleanPlex®RNA、CleanPlex®UMI和OmniFusion™ 为精确肿瘤学、传染病检测、遗传病检测、单细胞分析、分子育种和许多其他应用提供全面的解决方案。我们的技术和产品已被全球数百家著名的下一代测序（NGS）实验室采用。有了我们的平台，我们可以高效、快速地生产独特、定制的下一代测序（NGS）分析，以满足研究人员、测试实验室和生物制药精确医学项目的需求。
在一个月2019冠状病毒疾病基因组学中，我们可以开发出一种高质量的NGS检测。2019冠状病毒疾病的检测已被全球研究者和临床医生广泛采用，以对抗COVID-19流行。
Ready-to-Use Amplicon NGS Panels
Accessories
Kits for Illumina and Ion Torrent
Kits for MGI DNBSEQ Sequencers
To provide high-quality target enrichment solutions to the genomics community to advance precision medicine and research.
Headquartered in the San Francisco Bay Area, Paragon Genomics is a fast-growing precision medicine company. Our patented targeted sequencing technologies CleanPlex® DNA, CleanPlex® RNA, CleanPlex® UMI, and OmniFusion™ provide comprehensive solutions to precision oncology, infectious disease testing, inherited disease testing, single cell analysis, molecular breeding and many other applications. Our technologies and products have been adopted by hundreds of prominent Next-Generation Sequencing (NGS) labs globally. With our platforms, we can efficiently and rapidly produce unique and customized next-generation sequencing (NGS) assays to meet the needs of researchers, testing labs and biopharma precision medicine projects.
Paragon Genomics’ COVID-19 NGS assay developed within one month is a great example about how fast we can develop a high-quality NGS assay. This assay has been widely adopted by researchers and clinicians globally to fight the COVID-19 pandemic.
